2023-01-25 14:30:01 $ECON Economic Data
01/25/23 01/2514:30 01/25/2314:30 | U.S. economic calendar ThursdayU.S. economic calendar Thursday includes several interesting reports but none that will really impact the FOMC's decision in a week's time. Headlining is the Advance Q4 GDP report where analysts are forecasting a slowing to a 2.2% pace from the 3.2% in Q3. Analysts expect a 2.3% clip for real final sales. The chain price index should decelerate slightly to a 4.0% rate from 4.4% previously. Also slated Thursday are durable goods, jobless claims, new home sales, and the advance indicators. Friday's reports include income, consumption, and the FOMC's favorite PCE price index, along with the final consumer sentiment and inflation stats from the University of Michigan survey. |
---|
Syndicate
|
Quoin Pharmaceuticals files to sell $10M of ordinary shares »
06:05 02/03/23 02/0306:05 02/03/2306:05
QNRX
Quoin Pharmaceuticals
Represented by American… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Hexcel downgraded to Neutral from Buy at BofA »
06:05 02/03/23 02/0306:05 02/03/2306:05
HXL
Hexcel
BofA analyst Ronald… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Camden Property downgraded on 'market drag' at Piper Sandler »
06:04 02/03/23 02/0306:04 02/03/2306:04
CPT
Camden Property
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Ford downgraded to Sell from Hold at Deutsche Bank »
06:04 02/03/23 02/0306:04 02/03/2306:04
F
Ford
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Herbalife Nutrition initiated with an Underperform at BofA »
06:03 02/03/23 02/0306:03 02/03/2306:03
HLF
Herbalife Nutrition
BofA analyst Anna Liznul… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Vyant Bio announces reduction in force and other measures to preserve cash »
06:03 02/03/23 02/0306:03 02/03/2306:03
VYNT
Vyant Bio
Vyant Bio announced that… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Alphabet price target raised to $155 from $130 at Oppenheimer »
06:02 02/03/23 02/0306:02 02/03/2306:02
GOOG
Alphabet
Oppenheimer analyst Jason… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Cigna reports Q4 adjusted EPS $4.96, consensus $4.86 »
06:02 02/03/23 02/0306:02 02/03/2306:02
CI
Cigna
Reports Q4 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Paylocity price target raised to $297 from $276 at Piper Sandler »
06:02 02/03/23 02/0306:02 02/03/2306:02
PCTY
Paylocity
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Johnson Outdoors reports Q1 EPS 57c vs. $1.07 a year ago »
06:02 02/03/23 02/0306:02 02/03/2306:02
JOUT
Johnson Outdoors
Reports Q1 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Direct Line Insurance downgraded to Underweight from Equal Weight at Barclays »
06:00 02/03/23 02/0306:00 02/03/2306:00
DIISY
Direct Line Insurance
Barclays analyst Ivan… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Creative Media & Community Trust acquires three multifamily assets »
05:59 02/03/23 02/0305:59 02/03/2305:59
CMCT
Creative Media & Community Trust
CMCT announced that it is… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
MAA price target raised to $190 from $180 at JMP Securities »
05:58 02/03/23 02/0305:58 02/03/2305:58
MAA
MAA
JMP Securities analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
H.B. Fuller upgraded to Buy from Neutral at Citi »
05:58 02/03/23 02/0305:58 02/03/2305:58
FUL
H.B. Fuller
Citi analyst Eric Petrie… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
XPeng launches G9 SUV, P7 sports sedan in European markets »
05:57 02/03/23 02/0305:57 02/03/2305:57
XPEV
XPeng
XPeng launched its two… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Repare Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley »
05:55 02/03/23 02/0305:55 02/03/2305:55
RPTX
Repare Therapeutics
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
General news
| Energy Action: Oil prices… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Neurocrine upgraded to Overweight from Equal Weight at Morgan Stanley »
05:54 02/03/23 02/0305:54 02/03/2305:54
NBIX
Neurocrine
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Immuneering downgraded to Underweight from Equal Weight at Morgan Stanley »
05:53 02/03/23 02/0305:53 02/03/2305:53
IMRX
Immuneering
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Sanofi sees 2023 business EPS up at low single digit rate at CER »
05:53 02/03/23 02/0305:53 02/03/2305:53
SNY
Sanofi
Sanofi expects 2023… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Esperion upgraded to Equal Weight from Underweight at Morgan Stanley »
05:52 02/03/23 02/0305:52 02/03/2305:52
ESPR
Esperion
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Sanofi reports Q4 business EPS EUR 1.71, up 17.4% at CER »
05:52 02/03/23 02/0305:52 02/03/2305:52
SNY
Sanofi
IFRS EPS for Q4 was EUR… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Erasca upgraded to Overweight from Equal Weight at Morgan Stanley »
05:51 02/03/23 02/0305:51 02/03/2305:51
ERAS
Erasca
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Cyteir downgraded to Underweight from Equal Weight at Morgan Stanley »
05:50 02/03/23 02/0305:50 02/03/2305:50
CYT
Cyteir Therapeutics
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Meta Platforms downgraded to Reduce from Hold at HSBC »
05:48 02/03/23 02/0305:48 02/03/2305:48
META
Meta Platforms
HSBC analyst Nicolas… HSBC analyst Nicolas Cote-Colisson downgraded Meta Platforms to Reduce from Hold with an unchanged price target of $110. The company's Q4 results showed higher engagement, but revenue was still down, the analyst tells investors in a research note. The firm says headwinds for the company include the macro environment, competition and regulation versus one "longer-term tailwind that is Meta's lead in Metaverse." The recent share rally leads HSBC to downgrade the shares to Reduce. ShowHide Related Items >><<
|